Gold prices steady amid Fed rate cut hopes; Trump-Putin talks awaited
LONDON - GSK plc, the global healthcare company, has released its Annual Report for the fiscal year ending December 31, 2024. The report was published on the company’s website today and is also set to be filed with the UK Financial Conduct Authority’s National Storage Mechanism (NSM).
The document provides a comprehensive overview of GSK’s financial performance and strategic developments throughout the year. It has been made available to the public in accordance with the Financial Conduct Authority’s Listing Rule 6.4.1R. Interested parties can access the report through the NSM or directly via the company’s dedicated annual report website.
In line with corporate governance practices, GSK will distribute hard copies of the Annual Report 2024 and the Notice of Annual General Meeting 2025 to shareholders who prefer paper communications around March 24, 2025. The same information will be accessible to other shareholders electronically on the same date.
The publication of the Annual Report is a regulatory requirement and is intended to provide shareholders and the market with detailed information about GSK’s financial health and business trajectory. The report includes information necessary to comply with the FCA’s Disclosure Guidance and Transparency Rules (DTRs).
The announcement of the report’s release highlights GSK’s commitment to transparency and adherence to regulatory standards. It is important to note that this news article is based on the press release statement and does not substitute for a thorough review of the Annual Report 2024 itself.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.